Oregon Health & Science University Hospital is a 576-bed teaching hospital, biomedical research facility, and Level I trauma center located on the campus of Oregon Health & Science University in Portland in the U.S. state of Oregon.

There are 576 beds in Oregon Health & Science University Hospital.

During the past decade, Oregon Health & Science University Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 6 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Health & Science University Hospital" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials, followed by "Oregon Health and Science University" with 3 trials sponsored, "University of Michigan" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Gregory W Albers" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Health & Science University Hospital" #1 collaborator was "Medical University of South Carolina" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "University of Cincinnati" with 2 trials as a collaborator, "University of Pittsburgh" with 2 trials as a collaborator and "Canadian Cancer Society (CCS)" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Health & Science University Hospital" are "Ischemic Stroke" (2 trials), "ARDS" (1 trials), "Acute Coronary Syndrome (ACS)" (1 trials), "Age-Related Cognitive Decline" (1 trials) and "Anticoagulants" (1 trials). Many other conditions were trialed in "Oregon Health & Science University Hospital" in a lesser frequency.

Most popular intervention types in "Oregon Health & Science University Hospital" are "Device" (10 trials), "Drug" (7 trials), "Other" (4 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "24-Hour Prophylactic Cefazolin* Antibiotic Regimen" (1 trials), "5-Days Prophylactic Cefazolin* Antibiotic Regimen" (1 trials), "Acute Care of Elders focused geriatric care" (1 trials), "Apixaban" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Health & Science University Hospital" are 22 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Oregon Health & Science University Hospital". 1 are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Oregon Health & Science University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Health & Science University Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".